News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Venetoclax and Pegcrisantaspase for Relapsed or Refractory Acute Myeloid Leukemia
Yuchen Liu/sightmd.com
Nov 2, 2024, 17:34

Venetoclax and Pegcrisantaspase for Relapsed or Refractory Acute Myeloid Leukemia

Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of Chicago, shared a recent article by Yuchen Liu on X:

“Very interesting study in Blood Journal looking at Pegcrisantaspase + Ven in R/R AML (68% of patients with prior Ven exposure)!”

Venetoclax and Pegcrisantaspase for Relapsed or Refractory Acute Myeloid Leukemia

A phase 1 study of the amino acid modulator pegcrisantaspase and venetoclax in relapsed or refractory acute myeloid leukemia.

Authors: Yuchen Liu, et al.

Venetoclax and Pegcrisantaspase for Relapsed or Refractory Acute Myeloid Leukemia

 

Acute Myeloid Leukemia AML Anand Patel Blood Journal cancer OncoDaily Oncology Pegcrisantaspase venetoclax Yuchen Liu
Special Coverage
Insight
Nov 2, 2024, 17:34
Venetoclax and Pegcrisantaspase for Relapsed or Refractory Acute Myeloid Leukemia
Positive
Nov 2, 2024, 16:16
University of Texas System Board of Regents Announces 2024 Regents Outstanding Teaching Awards Recipients
Immunotherapy
Nov 2, 2024, 15:51
Immunotherapy for Metastatic Colon Cancer: Types, Success Rate, Side Effects & More
Blog
Nov 2, 2024, 15:31
NIH-funded scientists uncover clues to precancer and tumor biology
Blog
Nov 2, 2024, 15:23
Nico Nortje: Thought provoking day at ASCO Ethics Committee meeting
Blog
Nov 2, 2024, 15:02
Highlights from the 2024 Alliance for Clinical Trials in Oncology Fall Meeting
Insight
Nov 2, 2024, 14:46
Myeloma Paper of the Day, November 2nd, suggested by Robert Orlowski
Insight
Nov 2, 2024, 12:52
When to stop ICIs in dMMR/MSI-H metastatic colorectal cancer
Insight
Nov 2, 2024, 12:42
Pavlos Msaouel: How the observed adjuvant immunotherapy trial result discrepancies in kidney cancer
Blog
Nov 2, 2024, 12:12
OncoInfluencers to Follow on Social Media: Dr. Monika Pansari
Blog
Nov 2, 2024, 12:09
What if AI could transform the way we diagnose lung cancer? - UICC
Positive
Nov 2, 2024, 12:01
Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024